INNOVATION THAT MATTERS

SAGE Therapeutics on Fast Track towards CNS Cures

An Interview with Dr. Albert Robichaud, CSO of SAGE Therapeutics

CNS disorders represent 35 percent of the worldwide disease burden and one of the largest global health care markets. Read more.

Partner in News: TruTag Uses 'Edible Barcodes' in Fight against Counterfeit Drug Trade

TruTag Uses 'Edible Barcodes' in Fight against Counterfeit Drug Trade

Who knew that the answer to fighting the trillion-dollar global counterfeit drug problem rested in a particle the size of a speck of dust? Read more.

---

PERSPECTIVES

Overcoming Challenges in Developing Antibody Drugs Against Immune Check Point Targets - An Interview with Dr. Jing Li, Vice President, WuXi Biologics
WuXi Israel Office Opening and IATI BioMed: An Interview with Felix Hsu, SVP, US Business Unit

WuXi Israel Office Opening and IATI BioMed: An Interview with Felix Hsu, SVP, US Business Unit

With the rapid growth of Israel’s biotech and pharma industries in the past few years, WuXi proudly opened its Israel office in early 2015.  Read more.

---

FDA APPROVALS AND DESIGNATIONS

---

Subscribe to our Newsletter!

Email us at communications@wuxiapptec.com for your important clinical milestones and we will share it with our community. 

---
---

Thank you for your support in helping WuXi reach where we are today. We will continue with our goal - to serve you better with our integrated technology and capability platform.
 Office of Corporate Communications, WuXi AppTec

Web: www.wuxiapptec.com/wxpress | Email: communications@wuxiapptec.com